Comparative Binding Energy (COMBINE) Analysis Supports a Proposal for the Binding Mode of Epothilones to β‐Tubulin

The conformational preferences of epothilone A (EPA) and a 12,13‐cyclopropyl C12‐epimerized analogue were explored in aqueous solution using molecular dynamics simulations. The simulated conformers that provided an optimal fit in the paclitaxel binding site of mammalian β‐tubulin were then selected. The resulting modeled complexes were simulated before and after refinement of the M‐loop to improve the fitting and assess ligand stability within the binding pocket. The tubulin‐bound conformation of EPA was found to be unlike a previously reported solution obtained through mixed crystallographic/NMR/modeling studies. However, our conformation was in agreement with an NMR‐based proposal although the exact binding pose within the site was different. Molecular models were built for the complexes of 14 epothilone derivatives with β‐tubulin. A projection to latent structures regression method succeeded in providing a good prediction of the experimentally measured binding enthalpies for the whole set of ligands by assigning weights to a selection of interaction energy terms. These receptor‐based, quantitative structure–activity relationships support the proposed binding mode, help confirm and interpret previously acquired experimental data, shed additional light on the effect of several β‐tubulin mutations on ligand binding, and can potentially direct further experimental studies.

[1]  J. Snyder,et al.  The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. , 2012, Current medicinal chemistry. Anti-cancer agents.

[2]  K. Altmann,et al.  The biology and medicinal chemistry of epothilones. , 2012, Current medicinal chemistry. Anti-cancer agents.

[3]  J. Snyder,et al.  C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle. , 2011, Chemistry.

[4]  George M. Whitesides,et al.  Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase , 2011, Proceedings of the National Academy of Sciences.

[5]  K. Altmann,et al.  Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives , 2011, Molecular Diversity.

[6]  Marcel Knossow,et al.  The determinants that govern microtubule assembly from the atomic structure of GTP-tubulin. , 2011, Journal of molecular biology.

[7]  Tjelvar S. G. Olsson,et al.  Extent of enthalpy–entropy compensation in protein–ligand interactions , 2011, Protein science : a publication of the Protein Society.

[8]  E. Mandelkow,et al.  Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy. , 2010, Angewandte Chemie.

[9]  C. Dumontet,et al.  Microtubule-binding agents: a dynamic field of cancer therapeutics , 2010, Nature Reviews Drug Discovery.

[10]  A. Navarro‐Vázquez,et al.  The Binding Mode of Side Chain‐ and C3‐Modified Epothilones to Tubulin , 2010, ChemMedChem.

[11]  Arieh Warshel,et al.  A comprehensive examination of the contributions to the binding entropy of protein–ligand complexes , 2010, Proteins.

[12]  K. Altmann,et al.  Evaluation of Novel Epothilone Analogues by means of a Common Pharmacophore and a QSAR Pseudoreceptor Model for Taxanes and Epothilones , 2010, ChemMedChem.

[13]  Antonio Morreale,et al.  gCOMBINE: A graphical user interface to perform structure‐based comparative binding energy (COMBINE) analysis on a set of ligand‐receptor complexes , 2010, Proteins.

[14]  J. Hunt Discovery of Ixabepilone , 2009, Molecular Cancer Therapeutics.

[15]  Adnan Memic,et al.  How Do Halogen Substituents Contribute to Protein‐Binding Interactions? A Thermodynamic Study of Peptide Ligands with Diverse Aryl Halides , 2008, Chembiochem : a European journal of chemical biology.

[16]  R. Himes,et al.  The paclitaxel site in tubulin probed by site‐directed mutagenesis of Saccharomyces cerevisiae β‐tubulin , 2008, FEBS letters.

[17]  Federico Gago,et al.  Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel. , 2008, Chemistry & biology.

[18]  S. Swain,et al.  The Epothilones: Translating from the Laboratory to the Clinic , 2008, Clinical Cancer Research.

[19]  K. Altmann,et al.  Conformational preferences of natural and C3-modified epothilones in aqueous solution. , 2008, Journal of medicinal chemistry.

[20]  Gerald H Lushington,et al.  Whither combine? New opportunities for receptor-based QSAR. , 2007, Current medicinal chemistry.

[21]  T. Carlomagno,et al.  High‐Resolution Solid‐State NMR Structure of an Anticancer Agent , 2007, ChemMedChem.

[22]  K. Nicolaou,et al.  The Chemistry and Biology of Epothilones—The Wheel Keeps Turning , 2007, ChemMedChem.

[23]  Jens Meiler,et al.  Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution. , 2007, Angewandte Chemie.

[24]  J. Snyder,et al.  Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules , 2006, Molecular Cancer Therapeutics.

[25]  Lenwood S. Heath,et al.  H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..

[26]  W. Schubert,et al.  Lange gesucht – die bioaktive Konformation von Epothilon und seine Bindung im Tubulin , 2005 .

[27]  D. Heinz,et al.  Much anticipated--the bioactive conformation of epothilone and its binding to tubulin. , 2005, Angewandte Chemie.

[28]  Richard E. Taylor,et al.  Conformation-activity relationships in polyketide natural products. Towards the biologically active conformation of epothilone. , 2004, Organic & biomolecular chemistry.

[29]  Ben Cornett,et al.  The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography , 2004, Science.

[30]  David Baker,et al.  Protein structure prediction and analysis using the Robetta server , 2004, Nucleic Acids Res..

[31]  Federico Gago,et al.  Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles. , 2004, Journal of the American Chemical Society.

[32]  A. Ritzén,et al.  Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. , 2004, Chemistry & biology.

[33]  T. Poulos,et al.  Crystal Structures of Epothilone D-bound, Epothilone B-bound, and Substrate-free Forms of Cytochrome P450epoK* , 2003, Journal of Biological Chemistry.

[34]  Jens Meiler,et al.  The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents. , 2003, Angewandte Chemie.

[35]  Claudia J. Bode,et al.  Understanding tubulin–Taxol interactions: Mutations that impart Taxol binding to yeast tubulin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Claudia J. Bode,et al.  Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules. , 2002, Biochemistry.

[37]  E. Nogales,et al.  Refined structure of alpha beta-tubulin at 3.5 A resolution. , 2001, Journal of molecular biology.

[38]  S. Horwitz,et al.  MUTATIONS IN BETATUBULIN MAP TO DOMAINS INVOLVED IN REGULATION OF MICROTUBULE STABILITY IN EPOTHILONE-RESISTANT CELL LINES , 2001 .

[39]  R. Wade,et al.  Microtubule structure at improved resolution. , 2001, Biochemistry.

[40]  K. Varani,et al.  Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy? , 2000, Biochemical pharmacology.

[41]  Y. Engelborghs,et al.  Molecular Recognition of Taxol by Microtubules , 2000, The Journal of Biological Chemistry.

[42]  D. Kingston,et al.  A common pharmacophore for Taxol and the epothilones based on the biological activity of a taxane molecule lacking a C-13 side chain. , 2000, Biochemistry.

[43]  E. Nogales,et al.  A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Kuduk,et al.  A common pharmacophore for cytotoxic natural products that stabilize microtubules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Nogales,et al.  High-Resolution Model of the Microtubule , 1999, Cell.

[46]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[47]  M Pastor,et al.  Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. , 1998, Journal of medicinal chemistry.

[48]  K. Nicolaou,et al.  Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, abd Cytotoxic Action against Taxol-Resistant Tumor Cells† , 1997 .

[49]  K. Nicolaou,et al.  Gezielt entworfene Epothilone: kombinatorische Synthese, Induktion der Tubulin‐Polymerisation und cytotoxische Wirkung gegen taxolresistente Tumorzellen , 1997 .

[50]  H. Reichenbach,et al.  Epothilon A und B – neuartige, 16gliedrige Makrolide mit cytotoxischer Wirkung: Isolierung, Struktur im Kristall und Konformation in Lösung† , 1996 .

[51]  H. Reichenbach,et al.  Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution† , 1996 .

[52]  H Irschik,et al.  Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. , 1996, The Journal of antibiotics.

[53]  E. Lazarides,et al.  Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.

[54]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[55]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[56]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[57]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[58]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[59]  Marcel Knossow,et al.  The binding of vinca domain agents to tubulin: structural and biochemical studies. , 2010, Methods in cell biology.

[60]  Gerhard Klebe,et al.  Adding calorimetric data to decision making in lead discovery: a hot tip , 2010, Nature Reviews Drug Discovery.

[61]  H. Abdi Partial least squares regression and projection on latent structure regression (PLS Regression) , 2010 .

[62]  I. Barasoain,et al.  Fluorescent taxoid probes for microtubule research. , 2010, Methods in cell biology.

[63]  G. Scuseria,et al.  Gaussian 03, Revision E.01. , 2007 .

[64]  James M. Briggs,et al.  Comparative molecular field analysis (CoMFA) study of epothilones – tubulin depolymerization inhibitors: Pharmacophore development using 3D QSAR methods , 2001, J. Comput. Aided Mol. Des..